Search
Lutetium Lu 177 dotatate
go.drugbank.com/drugs/DB13985ApprovedInvestigationalIt is a first radiopharmaceutical agent to be approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and is indicated for adult patients with somatostatin receptor-positive GEP-NETs [L1191 … Lutetium Lu 177 dotatate was approved by the FDA as Lutathera in January 2018 for intravenous injection.
Products: LUTATHERA SOLUTION FOR INFUSION 370 MBQ/MLRomosozumab
go.drugbank.com/drugs/DB11866ApprovedInvestigationalIn a comparison study of post menopausal women with osteoporosis and a past fracture, romosozumab for 12 months followed by alendronic acid for 12 months was superior to alendronic acid alone for 24 months … Romosozumab is a humanized monoclonal antibody indicated for the treatment of osteoperosis in postmenopausal women at high risk of fracture and patients who have failed in other treatments or are intolerant
Categories: Drugs for Treatment of Bone DiseasesProducts: EVENITY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 105 MG/1.17 ML, EVENITY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 105MG/1.17MLBordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)
go.drugbank.com/drugs/DB10788ApprovedInvestigationalBordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture.
Mixtures: , Suspension for Injection, ADACEL SUSPENSION FOR INJECTIONProducts: PERTAGEN® SUSPENSION FOR INJECTION 0.5 ML/DOSEPlantago ovata seed
go.drugbank.com/drugs/DB14585ApprovedWithdrawnCategories: Drugs for ConstipationProducts: EVAGEL POWDER FOR ORAL SOLUTION 3.5g, CONSIGEL POWDER FOR ORAL SOLUTION 3.5GDecitabine
go.drugbank.com/drugs/DB01262ApprovedInvestigational[A2263, A2264, A2265, A215317, L14962] Decitabine was developed by MGI Pharma/SuperGen Inc. and was approved by the FDA for the treatment of MDS on February 5, 2006.
Products: DACOGEN (Decitabine) 50 mg Powder for Concentrate for Solution for Infusion, Redtibin (Decitabine) Powder for Injection 50mg/vialTreosulfan
go.drugbank.com/drugs/DB11678ApprovedInvestigationalTreosulfan is a prodrug alternative to [busulfan] for myeloablative conditioning prior to hematopoietic stem cell transplantation. … [L52245] It was approved by the EMA in June 2019[L16965] and by the FDA in January 2025 for use in combination with [fludarabine].[L52575]
Products: Treosulfan for InjectionFerric carboxymaltose
go.drugbank.com/drugs/DB08917ApprovedInvestigationalFerric carboxymaltose is an iron replacement product and, chemically, an iron-carbohydrate complex. It was FDA approved on July 25, 2013.
Products: Ferinject Solution for Injection 50mg/ml, Ferinject® 50 mg iron/mL solution for injection/infusionEucalyptol
go.drugbank.com/drugs/DB03852ApprovedInvestigationalNutraceuticalEucalyptol is an effective treatment for nonpurulent rhinosinusitis. Eucalyptol reduces inflammation and pain when applied topically. It kills leukaemia cells in vitro.
Mixtures: Keloid Healer Synergy for treatment of keloidsProducts: Rosatra Synergy for treatment of Acne RosaceaRavulizumab
go.drugbank.com/drugs/DB11580ApprovedInvestigational[A244465] It was later approved by the European Commission on July 2, 2019, for the same indications.[L39710] Ravulizumab is also used to treat myasthenia gravis. … [A244465] Ravulizumab was first approved by the FDA on December 21, 2018, for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome in children and adults.
Products: Ultomiris 100mg/mL Concentrate For Solution For InfusionCalcium chloride
go.drugbank.com/drugs/DB01164ApprovedInvestigationalIt has several common applications such as brine for refrigeration plants, ice and dust control on roads, and in cement.
Mixtures: ARTISS - Lösungen für einen Gewebekleber, Tisseel - Lösungen für einen GewebekleberProducts: Calcium Chloride for Haemodialysis, Calcium Chloride Bp - Additive for Concentrated Haemodialysis Solutions